Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 23, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, classified psilocybin as a…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jul 15, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 8, 2026 0

The landscape of mental health treatment is on the cusp of a profound transformation, with psilocybin, a compound once relegated…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jun 30, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
Pharmaceutical R&D

US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs

Teuku Ryan Apr 8, 2026 0

The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…

Read More
Cornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic DisruptionFDA Leadership Turmoil Intensifies as Key Officials Ousted Amidst Political ManeuveringMolecular Switch Discovery at Weill Cornell Medicine Enhances Blood Stem Cell Regeneration and Bone Marrow Transplant EfficacyStanford Researchers Uncover Glucose’s Secret Role as a Master Architect of Human Tissue Development
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ